# Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma

> **NCT01377532** · — · APPROVED_FOR_MARKETING · sponsor: **University of California, San Francisco**

## Conditions studied

- Pheochromocytoma
- Paraganglioma

## Interventions

- **DRUG:** 131 I-Metaiodobenzylguanidine (131 I-MIBG)

## Key facts

- **NCT ID:** NCT01377532
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** APPROVED_FOR_MARKETING
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2020-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01377532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01377532, "Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01377532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*